Qube Research & Technologies LTD Biodesix Inc Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Biodesix Inc stock. As of the latest transaction made, Qube Research & Technologies LTD holds 3,068 shares of BDSX stock, worth $5,491. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,068
Previous 69,497
95.59%
Holding current value
$5,491
Previous $99,000
95.96%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BDSX
# of Institutions
51Shares Held
53.6MCall Options Held
500Put Options Held
11.5K-
Telemark Asset Management, LLC Boston, MA8.28MShares$14.8 Million1.22% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT6.11MShares$10.9 Million0.95% of portfolio
-
Aigh Capital Management LLC Baltimore, MD5.78MShares$10.3 Million3.2% of portfolio
-
Birchview Capital, LP Burlington, VT5.54MShares$9.92 Million8.47% of portfolio
-
Sio Capital Management, LLC New York, NY4.35MShares$7.78 Million2.48% of portfolio
About BIODESIX INC
- Ticker BDSX
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 39,982,000
- Market Cap $71.6M
- Description
- Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pat...